Like any news-focused media company, Newsmax (NYSE: NMAX) centers its business on bad news. Its share price has already fallen over 70% since the initial public offering (IPO) in March. Is Newsmax ...

We recently published a list of Biotech Stocks Dominate Monday’s Top 10 Gainers. In this article, we are going to take a look at where Newsmax Inc. (NYSE:NMAX) stands against other biotech stocks that ...